| No headlines available for GIOTX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 562.19M | | Category: | Foreign Large Value | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 18.97% | | 5y Avg Return: | N/A | | Rank in Category (ytd): | 319 | | % Rank in Category (ytd): | 93.82% | | Beta (3y): | 0.90 | | Morningstar Risk Rating: | Below average |
|
| The investment seeks total return greater than its benchmark MSCI EAFE index. The fund is a fund of funds and invests primarily in shares of the GMO International Equity Funds which may include GMO Emerging Countries Fund and GMO Emerging Markets Quality Fund. It may also invest in other GMO mutual funds. The fund normally invests at least 80% of assets in equity investments. | | | Fund Profile |
|